HK1220461A1 - 組蛋白去乙酰酶抑制劑,其組合物及其使用方法 - Google Patents
組蛋白去乙酰酶抑制劑,其組合物及其使用方法Info
- Publication number
- HK1220461A1 HK1220461A1 HK16108599.0A HK16108599A HK1220461A1 HK 1220461 A1 HK1220461 A1 HK 1220461A1 HK 16108599 A HK16108599 A HK 16108599A HK 1220461 A1 HK1220461 A1 HK 1220461A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- compositions
- methods
- histone deacetylase
- deacetylase inhibitors
- inhibitors
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/26—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Diabetes (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Communicable Diseases (AREA)
- Immunology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Oncology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Psychology (AREA)
- Urology & Nephrology (AREA)
- Endocrinology (AREA)
- Virology (AREA)
- Emergency Medicine (AREA)
- Psychiatry (AREA)
- Rheumatology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201361785759P | 2013-03-14 | 2013-03-14 | |
PCT/US2014/022535 WO2014159210A1 (en) | 2013-03-14 | 2014-03-10 | Histone deacetylase inhibitors and compositions and methods of use thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1220461A1 true HK1220461A1 (zh) | 2017-05-05 |
Family
ID=51625122
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK16108599.0A HK1220461A1 (zh) | 2013-03-14 | 2016-07-19 | 組蛋白去乙酰酶抑制劑,其組合物及其使用方法 |
Country Status (7)
Country | Link |
---|---|
US (2) | US9562021B2 (zh) |
EP (1) | EP2968232B1 (zh) |
JP (1) | JP6363164B2 (zh) |
AR (1) | AR095352A1 (zh) |
HK (1) | HK1220461A1 (zh) |
TW (1) | TW201514153A (zh) |
WO (1) | WO2014159210A1 (zh) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9783488B2 (en) | 2013-03-14 | 2017-10-10 | Chdi Foundation, Inc. | Histone deacetylase inhibitors and compositions and methods of use thereof |
JP6363164B2 (ja) * | 2013-03-14 | 2018-07-25 | シーエイチディーアイ ファウンデーション,インコーポレーテッド | ヒストンデアセチラーゼ阻害剤及びその組成物と使用方法 |
US9617259B2 (en) | 2013-03-14 | 2017-04-11 | Chdi Foundation, Inc. | Histone deacetylase inhibitors and compositions and methods of use thereof |
CA2951026A1 (en) | 2014-06-02 | 2015-12-10 | Chdi Foundation, Inc. | Histone deacetylase inhibitors and compositions and methods of use thereof |
US10357493B2 (en) | 2017-03-10 | 2019-07-23 | Selenity Therapeutics (Bermuda), Ltd. | Metalloenzyme inhibitor compounds |
TWI670068B (zh) * | 2017-04-21 | 2019-09-01 | 大江生醫股份有限公司 | 花生膜萃取物於提升ptprd基因表現之應用 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20090094383A (ko) * | 2006-12-19 | 2009-09-04 | 메틸진 인크. | 히스톤 탈아세틸화효소의 억제제 및 이의 프로드럭 |
WO2008101186A1 (en) * | 2007-02-15 | 2008-08-21 | The J. David Gladstone Institutes | Inhibitors for hdac8 |
CN101679220A (zh) * | 2007-04-09 | 2010-03-24 | 梅特希尔基因公司 | 组蛋白脱乙酰酶抑制剂 |
BRPI0817897A2 (pt) * | 2007-11-02 | 2019-09-24 | Methylgene Inc | composto, composição, e, métodos de inibição da atividade hdac, e de tratamento de uma doença responsiva a um inibidor de atividade hdac |
CN101863901B (zh) * | 2010-06-29 | 2012-12-05 | 天津药物研究院 | 2-(取代苯基)-2-(4,5,6,7-四氢噻吩并[3,2-c]吡啶-5(4H)-基)-N-取代-乙酰胺、其制备方法和用途 |
TW201245115A (en) | 2011-01-24 | 2012-11-16 | Chdi Foundation Inc | Histone deacetylase inhibitors and compositions and methods of use thereof |
AR091773A1 (es) | 2012-07-16 | 2015-02-25 | Chdi Foundation Inc | Inhibidores de la histona desacetilasa y composiciones y sus metodos de uso |
US9783488B2 (en) | 2013-03-14 | 2017-10-10 | Chdi Foundation, Inc. | Histone deacetylase inhibitors and compositions and methods of use thereof |
JP6363164B2 (ja) * | 2013-03-14 | 2018-07-25 | シーエイチディーアイ ファウンデーション,インコーポレーテッド | ヒストンデアセチラーゼ阻害剤及びその組成物と使用方法 |
US9617259B2 (en) | 2013-03-14 | 2017-04-11 | Chdi Foundation, Inc. | Histone deacetylase inhibitors and compositions and methods of use thereof |
WO2014159214A1 (en) | 2013-03-14 | 2014-10-02 | Chdi Foundation, Inc. | Histone deacetylase inhibitors and compositions and methods of use thereof |
CA2951026A1 (en) | 2014-06-02 | 2015-12-10 | Chdi Foundation, Inc. | Histone deacetylase inhibitors and compositions and methods of use thereof |
-
2014
- 2014-03-10 JP JP2016500992A patent/JP6363164B2/ja active Active
- 2014-03-10 US US14/776,039 patent/US9562021B2/en active Active
- 2014-03-10 EP EP14773968.4A patent/EP2968232B1/en active Active
- 2014-03-10 WO PCT/US2014/022535 patent/WO2014159210A1/en active Application Filing
- 2014-03-14 AR ARP140101056A patent/AR095352A1/es unknown
- 2014-03-14 TW TW103109425A patent/TW201514153A/zh unknown
-
2016
- 2016-07-19 HK HK16108599.0A patent/HK1220461A1/zh unknown
-
2017
- 2017-01-20 US US15/411,535 patent/US10105363B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
EP2968232A1 (en) | 2016-01-20 |
US10105363B2 (en) | 2018-10-23 |
WO2014159210A1 (en) | 2014-10-02 |
EP2968232A4 (en) | 2016-08-03 |
TW201514153A (zh) | 2015-04-16 |
EP2968232B1 (en) | 2018-12-05 |
JP6363164B2 (ja) | 2018-07-25 |
AR095352A1 (es) | 2015-10-07 |
US9562021B2 (en) | 2017-02-07 |
US20160024019A1 (en) | 2016-01-28 |
JP2016512512A (ja) | 2016-04-28 |
US20170224684A1 (en) | 2017-08-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1252489A1 (zh) | 組蛋白去乙酰化酶抑制劑及其組合物和使用方法 | |
HRP20181381T1 (hr) | Novi inhibitori histon deacetilaze | |
IL280820A (en) | Histone deacetylase inhibitors | |
IL245926A0 (en) | Combinations of histone deacetylase inhibitors and immunomodulatory drugs | |
HK1220407A1 (zh) | 組蛋白去乙酰酶抑制劑,其組合物及其使用方法 | |
IL249339A0 (en) | Histone deacetylase inhibitors and compositions and methods of using them | |
HRP20181291T1 (hr) | Heterobicikloarilni inhibitori rorc2 i njihova upotreba | |
IL227379A0 (en) | Histone deacetylase inhibitors and compositions and methods of using them | |
HK1220461A1 (zh) | 組蛋白去乙酰酶抑制劑,其組合物及其使用方法 | |
HK1252487A1 (zh) | 組蛋白去乙酰化酶抑制劑及其組合物和使用方法 | |
IL236686A0 (en) | Inhibitors of histone deacetylase and compositions and methods of using them | |
HK1220406A1 (zh) | 組蛋白去乙酰酶抑制劑及組合物 | |
HK1204998A1 (zh) | 組蛋白脫乙醯酶抑制劑與帕唑帕尼的組合及其用途 |